Pre-market hot trades in US stocks: Texxon up 8.05% in pre-market; CVS Health up 7.30% in pre-market

Pre-market Hot Trades in US Stocks Texxon, up 8.05% in pre-market trading, has no significant recent news. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. CVS is up 7.30% in pre-market trading. Based on recent key news: On April 7, the U.S. government announced an increase in payment rates for private federal Medicare plans to 2.48% by 2027, far higher than the proposed 0.09% in January. This news boosted the stock prices of insurance companies like CVS, with an after-hours increase of 7.8%. Source: Reuters On April 7, CMS stated that this payment standard adjustment is expected to add $13 billion in reimbursement funds to the federal Medicare program, enhancing the operational space for insurance companies in premium design and benefit content. Source: CNBC On April 7, the head of CMS indicated that the adjusted payment standards would maintain the affordability of insurance coverage, ensuring that patients receive value from the insurance plans, further boosting market confidence. Source: CNBC The insurance industry is benefiting from favorable policies, with significant capital inflow. Top Gainers in Pre-market US Stocks Huachen AI Parking Management Tech, up 167.35% in pre-market trading, has no significant recent news. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Advanced Biomed is up 72.62% in pre-market trading. Based on recent key news: On April 7, Advanced Biomed announced the acquisition of Acellent, aiming to expand its technology portfolio, enhance operational efficiency, and support growth. This move drove the stock price up 82% in after-hours trading. Source: Nasdaq On April 4, Advanced Biomed signed a stock purchase agreement with Acellent Technologies, planning to acquire Acellent for 270,000 shares of common stock, with a total transaction value of approximately $1,080,000. This move is seen as the company's expansion into AI-driven financial verification and auditing solutions. Source: SEC announcement On April 4, Advanced Biomed expanded its product portfolio through strategic acquisitions, increasing its AI-driven financial verification capabilities, indicating its intention for business diversification, which may enhance its technological infrastructure and cross-industry positioning. Source: Simply Wall St The trend of industry diversification is significant, with a focus on AI technology. Ridgetech is up 68.85% in pre-market trading. Based on recent key news: On April 4, Ridgetech announced a 1-for-150 reverse stock split to be implemented on April 7. This move will reduce the common stock from approximately 135 million shares to about 890,000 shares, which may lead to stock price volatility Source: Press Release On April 3rd, Ridgetech's trading price on Nasdaq was $0.0246, down 11.51% from the previous trading day. The announcement of the reverse split has impacted the market's perception of its stock price. Source: RTTNews On April 4th, Ridgetech plans to consolidate shares through a reverse split, which may affect its stock value. This move aims to increase the share price and attract more investor attention. Source: PR Newswire The reverse split may impact market liquidity and investor confidence